依赖于 ATP 的人类 RISCs 组装途径。
ATP-dependent human RISC assembly pathways.
机构信息
Institute of Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan.
出版信息
Nat Struct Mol Biol. 2010 Jan;17(1):17-23. doi: 10.1038/nsmb.1733. Epub 2009 Dec 6.
Abstract
The assembly of RNA-induced silencing complex (RISC) is a key process in small RNA-mediated gene silencing. In humans, small interfering RNAs (siRNAs) and microRNAs (miRNAs) are incorporated into RISCs containing the Argonaute (AGO) subfamily proteins Ago1-4. Previous studies have proposed that, unlike Drosophila melanogaster RISC assembly pathways, human RISC assembly is coupled with dicing and is independent of ATP. Here we show by careful reexamination that, in humans, RISC assembly and dicing are uncoupled, and ATP greatly facilitates RISC loading of small-RNA duplexes. Moreover, all four human AGO proteins show remarkably similar structural preferences for small-RNA duplexes: central mismatches promote RISC loading, and seed or 3'-mid (guide position 12-15) mismatches facilitate unwinding. All these features of human AGO proteins are highly reminiscent of fly Ago1 but not fly Ago2.
摘要
RNA 诱导沉默复合物（RISC）的组装是小 RNA 介导的基因沉默的关键过程。在人类中，小干扰 RNA（siRNA）和 microRNA（miRNA）被整合到含有 Argonaute（AGO）亚家族蛋白 Ago1-4 的 RISC 中。先前的研究表明，与果蝇 RISC 组装途径不同，人类 RISC 组装与 Dicer 的切割过程解耦，并且不依赖于 ATP。在这里，我们通过仔细的重新检查表明，在人类中，RISC 组装和 Dicer 的切割过程是解耦的，并且 ATP 极大地促进了小 RNA 双链体加载到 RISC 中。此外，所有四种人类 AGO 蛋白对小 RNA 双链体表现出非常相似的结构偏好：中心错配促进 RISC 加载，而种子或 3'-mid（引导位置 12-15）错配促进解链。人类 AGO 蛋白的所有这些特征都非常类似于果蝇 Ago1，但不同于果蝇 Ago2。
相似文献
1
ATP-dependent human RISC assembly pathways.依赖于 ATP 的人类 RISCs 组装途径。
Nat Struct Mol Biol. 2010 Jan;17(1):17-23. doi: 10.1038/nsmb.1733. Epub 2009 Dec 6.
2
Structural determinants of miRNAs for RISC loading and slicer-independent unwinding.微小RNA（miRNA）用于RNA诱导沉默复合体（RISC）加载和不依赖核酸酶切割的解旋的结构决定因素。
Nat Struct Mol Biol. 2009 Sep;16(9):953-60. doi: 10.1038/nsmb.1630. Epub 2009 Aug 16.
3
Cleavage of the star strand facilitates assembly of some microRNAs into Ago2-containing silencing complexes in mammals.在哺乳动物中，星链的切割有助于一些微小RNA组装到含Ago2的沉默复合物中。
Mol Cells. 2008 Sep 30;26(3):308-13. Epub 2008 Aug 27.
4
Increased siRNA duplex stability correlates with reduced off-target and elevated on-target effects.siRNA 双链体稳定性的增加与降低脱靶效应和提高靶标效应相关。
RNA. 2011 Apr;17(4):737-49. doi: 10.1261/rna.2348111. Epub 2011 Mar 2.
5
A human, ATP-independent, RISC assembly machine fueled by pre-miRNA.一种由前体微小RNA驱动的、不依赖ATP的人类RNA诱导沉默复合体组装机器。
Genes Dev. 2005 Dec 15;19(24):2979-90. doi: 10.1101/gad.1384005.
6
Distinct roles for Argonaute proteins in small RNA-directed RNA cleavage pathways.AGO蛋白在小RNA介导的RNA切割途径中的不同作用。
Genes Dev. 2004 Jul 15;18(14):1655-66. doi: 10.1101/gad.1210204. Epub 2004 Jul 1.
7
Slicer function of Drosophila Argonautes and its involvement in RISC formation.果蝇AGO蛋白的切割功能及其在RISC形成中的作用
Genes Dev. 2005 Dec 1;19(23):2837-48. doi: 10.1101/gad.1370605. Epub 2005 Nov 14.
8
The N domain of Argonaute drives duplex unwinding during RISC assembly.Argonaute 的 N 结构域在 RISC 组装过程中驱动双链解旋。
Nat Struct Mol Biol. 2012 Jan 10;19(2):145-51. doi: 10.1038/nsmb.2232.
9
Native gel analysis for RISC assembly.用于RISC组装的天然凝胶分析。
Methods Mol Biol. 2011;725:91-105. doi: 10.1007/978-1-61779-046-1_7.
10
Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54.在人类细胞中，微小RNA诱导的基因沉默导致的翻译抑制需要RCK/p54。
PLoS Biol. 2006 Jul;4(7):e210. doi: 10.1371/journal.pbio.0040210.
引用本文的文献
1
MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathy.微小RNA：揭示糖尿病性心肌病的新机制及诊疗途径
Front Pharmacol. 2025 Jul 23;16:1613844. doi: 10.3389/fphar.2025.1613844. eCollection 2025.
2
The role of non-coding RNAs in the regulation of cell death pathways in melanoma.非编码RNA在黑色素瘤细胞死亡途径调控中的作用
Discov Oncol. 2025 Jun 11;16(1):1063. doi: 10.1007/s12672-025-02888-3.
3
NNT-AS1, A Long Non-coding RNA with Therapeutic Promise in Mycoplasma Pneumoniae Pneumonia via the Mir-410-3p/TMEM14A/Wnt/ΒCatenin Signalling Pathway.NNT-AS1，一种通过Mir-410-3p/TMEM14A/Wnt/β连环蛋白信号通路在支原体肺炎中具有治疗前景的长链非编码RNA。
Iran J Biotechnol. 2025 Jan 1;23(1). doi: 10.30498/ijb.2025.492048.4034. eCollection 2025 Jan.
4
MicroRNA nanoformulation: a promising approach to anti-tumour activity.微小RNA纳米制剂：一种有前景的抗肿瘤活性方法。
Invest New Drugs. 2025 May 14. doi: 10.1007/s10637-025-01534-7.
5
Decoding microRNA arm switching: a key to evolutionary innovation and gene regulation.解读微小RNA臂转换：进化创新与基因调控的关键
Cell Mol Life Sci. 2025 May 10;82(1):197. doi: 10.1007/s00018-025-05663-3.
6
Methods for Extracellular Vesicle Isolation: Relevance for Encapsulated miRNAs in Disease Diagnosis and Treatment.细胞外囊泡分离方法：对疾病诊断和治疗中封装的微小RNA的相关性
Genes (Basel). 2025 Mar 12;16(3):330. doi: 10.3390/genes16030330.
7
MicroRNAs' Significance in Retinoblastoma Diagnosis and Treatment: The Little Heroes.微小RNA在视网膜母细胞瘤诊断与治疗中的意义：小英雄们。
Biochem Genet. 2025 Apr;63(2):1176-1197. doi: 10.1007/s10528-024-10976-2. Epub 2025 Jan 25.
8
A guide to the biogenesis and functions of endogenous small non-coding RNAs in animals.动物体内内源性小非编码RNA的生物发生及功能指南
Nat Rev Mol Cell Biol. 2025 May;26(5):347-370. doi: 10.1038/s41580-024-00818-9. Epub 2025 Jan 24.
9
MiRNAs as major players in brain health and disease: current knowledge and future perspectives.微小RNA作为大脑健康与疾病的主要参与者：当前认知与未来展望
Cell Death Discov. 2025 Jan 13;11(1):7. doi: 10.1038/s41420-024-02283-x.
10
Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review).小RNA在炎症性肠病及相关结直肠癌中的新作用（综述）
Int J Mol Med. 2025 Feb;55(2). doi: 10.3892/ijmm.2024.5474. Epub 2024 Dec 20.
本文引用的文献
1
Structural determinants of miRNAs for RISC loading and slicer-independent unwinding.微小RNA（miRNA）用于RNA诱导沉默复合体（RISC）加载和不依赖核酸酶切割的解旋的结构决定因素。
Nat Struct Mol Biol. 2009 Sep;16(9):953-60. doi: 10.1038/nsmb.1630. Epub 2009 Aug 16.
2
The GW182 protein family in animal cells: new insights into domains required for miRNA-mediated gene silencing.动物细胞中的GW182蛋白家族：对miRNA介导的基因沉默所需结构域的新见解。
RNA. 2009 Aug;15(8):1433-42. doi: 10.1261/rna.1703809. Epub 2009 Jun 17.
3
Drosophila argonaute1 and argonaute2 employ distinct mechanisms for translational repression.果蝇AGO1和AGO2采用不同机制进行翻译抑制。
Mol Cell. 2009 Apr 10;34(1):58-67. doi: 10.1016/j.molcel.2009.02.010. Epub 2009 Mar 5.
4
Origins and Mechanisms of miRNAs and siRNAs.微小RNA（miRNA）和小干扰RNA（siRNA）的起源与机制。
Cell. 2009 Feb 20;136(4):642-55. doi: 10.1016/j.cell.2009.01.035.
5
Essential and overlapping functions for mammalian Argonautes in microRNA silencing.哺乳动物AGO蛋白在微小RNA沉默中的基本功能及重叠功能
Genes Dev. 2009 Feb 1;23(3):304-17. doi: 10.1101/gad.1749809. Epub 2009 Jan 27.
6
On the road to reading the RNA-interference code.解读RNA干扰密码之路。
Nature. 2009 Jan 22;457(7228):396-404. doi: 10.1038/nature07754.
7
Small silencing RNAs: an expanding universe.小干扰RNA：一个不断扩展的领域。
Nat Rev Genet. 2009 Feb;10(2):94-108. doi: 10.1038/nrg2504.
8
Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs.含人类AGO蛋白的核糖核蛋白复合物及其结合的靶标mRNA的分子特征分析
RNA. 2008 Dec;14(12):2580-96. doi: 10.1261/rna.1351608. Epub 2008 Oct 31.
9
Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing.内源性人类AGO蛋白及其miRNA伴侣在RNA沉默中的特征分析
Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):7964-9. doi: 10.1073/pnas.0800334105. Epub 2008 Jun 4.
10
Two molecular features contribute to the Argonaute specificity for the microRNA and RNAi pathways in C. elegans.两种分子特征促成了秀丽隐杆线虫中Argonaute蛋白对微小RNA和RNA干扰途径的特异性。
RNA. 2008 May;14(5):829-35. doi: 10.1261/rna.901908. Epub 2008 Mar 26.
Zotero 插件